✦ LIBER ✦

WHO International multicenter Listeria monocytogenes subtyping study—rationale and set-up of the study

✍ Scribed by J. Bille; J. Rocourt

Book ID: 114159402
Publisher: Elsevier Science
Year: 1996
Tongue: English
Weight: 611 KB
Volume: 32
Category: Article
ISSN: 0168-1605
DOI: 10.1016/s0168-1605(96)01140-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The WHO multicenter study on Listeria mo

The WHO multicenter study on Listeria monocytogenes subtyping: Random amplification of polymorphic DNA (RAPD)

✍ K. Wernars; P. Boerlin; A. Audurier; E.G. Russell; G.D.W. Curtis; L. Herman; N. 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 948 KB

High-frequency endonuclease (REA) typing

High-frequency endonuclease (REA) typing: results from the WHO collaborative study group on subtyping of Listeria monocytogenes

✍ P. Gerner-Smidt; P. Boerlin; F. Ischer; J. Schmidt 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 761 KB

Serotyping of 80 strains from the WHO mu

Serotyping of 80 strains from the WHO multicentre international typing study of Listeria monocytogenes

✍ A. Schönberg; E. Bannerman; A.L. Courtieu; R. Kiss; J. McLauchlin; S. Shah; D. W 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 422 KB

Genomic fingerprinting of 80 strains fro

Genomic fingerprinting of 80 strains from the WHO multicenter international typing study of Listeria monocytogenes via pulsed-field gel electrophoresis (PFGE)

✍ Roland Brosch; Maggie Brett; Benedicte Catimel; John B. Luchansky; Bente Ojeniyi 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 775 KB

Angiographic and clinical one-year follo

Angiographic and clinical one-year follow-up of the Cordis tantalum coil stent in a multicenter international study demonstrating improved restenosis rates when compared to pooled PTCA and BENESTENT-I data: The European Antiplatelet Stent Investigation (EASI)

✍ Martin T. Rothman; Patrick W. Serruys; Gilles Grollier; Jan C.A. Hoorntje; Arjan 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB 👁 3 views

An International, Multicenter, Randomize

An International, Multicenter, Randomized Phase III Study of First-Line Erlotinib Followed by Second-Line Cisplatin/Gemcitabine Versus First-Line Cisplatin/Gemcitabine Followed by Second-Line Erlotinib in Advanced Non–Small-Cell Lung Cancer: Treatment Rationale and Protocol Dynamics of the TORCH Trial

✍ Cesare Gridelli; Charles Butts; Fortunato Ciardiello; Ronald Feld; Ciro Gallo; F 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 91 KB